Thomas McCauley
Technik-/Wissenschafts-/F&E-Leiter bei OMEGA THERAPEUTICS, INC.
Vermögen: 41 928 $ am 31.05.2024
Aktive Positionen von Thomas McCauley
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
OMEGA THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2019 | - |
Karriereverlauf von Thomas McCauley
Ehemalige bekannte Positionen von Thomas McCauley
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Zikani Therapeutics, Inc.
Zikani Therapeutics, Inc. Drugstore ChainsRetail Trade Zikani Therapeutics, Inc. is a preclinical-stage company developing and commercializing novel therapeutics. The company was founded by Lawrence G. Miller and Andrew G. Myers in 2014 and is headquartered in Watertown, MA. | Corporate Officer/Principal | 01.09.2018 | 01.07.2019 |
TRANSLATE BIO, INC. | Corporate Officer/Principal | 01.09.2016 | 01.04.2018 |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Corporate Officer/Principal | 01.04.2010 | 01.08.2016 |
Ausbildung von Thomas McCauley
The University of Alabama at Birmingham | Doctorate Degree |
Cornell University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 7 |
Operativ
Corporate Officer/Principal | 3 |
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Retail Trade | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
OMEGA THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Zikani Therapeutics, Inc.
Zikani Therapeutics, Inc. Drugstore ChainsRetail Trade Zikani Therapeutics, Inc. is a preclinical-stage company developing and commercializing novel therapeutics. The company was founded by Lawrence G. Miller and Andrew G. Myers in 2014 and is headquartered in Watertown, MA. | Retail Trade |
Translate Bio, Inc.
Translate Bio, Inc. BiotechnologyHealth Technology Translate Bio, Inc. engages in the research and development of therapeutic drugs. It focuses on developing medicines to treat diseases caused by protein or gene dysfunction. Its lead product candidate, MRT5005 is designed for the treatment of cystic fibrosis. The company was founded by Arthur M. Krieg and Jeannie T. Lee in 2011 and is headquartered in Lexington, MA. | Health Technology |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Health Technology |
- Börse
- Insiders
- Thomas McCauley
- Erfahrung